Skip to main content

Peer Review reports

From: The efficacy of a cyclin dependent kinase 9 (CDK9) inhibitor, FIT039, on verruca vulgaris: study protocol for a randomized controlled trial

Original Submission
6 Jun 2018 Submitted Original manuscript
28 May 2019 Reviewed Reviewer Report - Freedom Nkululeko Gumedze
13 Jun 2019 Author responded Author comments - Takashi Nomura
Resubmission - Version 2
13 Jun 2019 Submitted Manuscript version 2
3 Jul 2019 Author responded Author comments - Takashi Nomura
Resubmission - Version 3
3 Jul 2019 Submitted Manuscript version 3
Publishing
11 Jul 2019 Editorially accepted
9 Aug 2019 Article published 10.1186/s13063-019-3570-6

You can find further information about peer review here.

Back to article page